The general
goal of our laboratory is to understand how bacterial and viral
pathogens
interface
with the host. We have focused on two mechanistic aspects of this interface:
(i)
the immunological detection and clearance of the infection,
and (ii) host systems utilized by the pathogen to facilitate infection.
Our work has focused on two pathogens: enteropathogenic E.coli (and
the related enterohemmorhagic E. coli, the cause of "raw hamburger
disease), and vaccinia virus (a relative of variola virus, the cause
of smallpox).
We have utilized a combination of experimental approaches including
cell
biology
assays
based on high
resolution
deconvolution
microscopy,
biochemical systems that permit reconstitution of cellular
responses with cytoplasmic extracts in permeablized cells, mouse genetic
systems
that model human disease, and permit investigation of the
immunological response to the pathogen, and a C. elegans model system
which allows
genetic dissection of both host
and
pathogen.
A long-term
goal
of the laboratory is to develop approaches that will permit identification
of agents useful in treating disease. There is considerable impetus
for developing such agents to treat infections caused by bacterial
and viral pathogens: development of resistance to antibiotic or other
chemotherapies looms as perhaps the single most important
public
health concern confronting humans in the coming century. In this regard,
our
current efforts have led to the development and testing of
novel inhibitors of pathogenic E.coli infections, which interfere with
the interface between host and pathogen but not
with bacterial growth. As such, these inhibitors
will not easily engender development of drug resistance.